Four new comedications have been added to the Anticoagulants, Antiplatelets and Fibrinolytic class. The new drugs are apixaban, dipyridamole, edoxaban and fondaparinux. All versions of the interaction charts (web, app and printable) have been updated with these new additions.
In related news, a new treatment selector for the class of Anticoagulants and Antiplatelets has been produced. Treatment selectors show interactions between key antiretrovirals and are designed to quickly show which antiretrovirals and co-medications are ‘more risky’ in relation to drug interactions. The new treatment can be found in the Interaction Charts | Treatment Selector section of the website.
